BASILEA PHARM.NA SF 1 revenue breakdown overview

BASILEA PHARM.NA SF 1 revenue for the last year amounted to 169.59 M EUR, the most of which — 169.63 M EUR — came from its highest performing source at the moment, Innovative Pharmaceutical Products, the year earlier bringing 149.30 M EUR. The greatest contribution to the revenue figure was made by Ireland — last year it brought BASILEA PHARM.NA SF 1 73.93 M EUR, and the year before that — 41.73 M EUR.